Inactive Instrument

News Tonix Pharmaceuticals Holding Corp Nasdaq

Equities

US8902602015

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Jul. 09	Tonix Pharmaceuticals Prices $4 Million Public Offering; Shares Plunge	MT
Jul. 09	Tonix Pharmaceuticals Holding Corp. announced that it expects to receive $30 million in funding	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering	Jul. 10	AQ
Tonix Pharmaceuticals Prices $4 Million Public Offering; Shares Plunge	Jul. 09	MT
Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya for the Management of Fibromyalgia	Jul. 09	AQ
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering	Jul. 09	AQ
Tonix Pharmaceuticals Holding Corp. announced that it expects to receive $30 million in funding	Jul. 08	CI
Tonix Pharmaceuticals Intends to Offer and Sell Shares of its Common Stock	Jul. 08	CI
Tonix Pharmaceuticals Plans Stock Offering; Shares Fall After-Hours	Jul. 08	MT
Tonix Pharmaceuticals Announces Proposed Public Offering	Jul. 08	AQ
Tonix Pharmaceuticals Gets FDA Nod to Proceed With New Drug Application for Tonmya in Fibromyalgia	Jul. 08	MT
Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya™ for the Management of Fibromyalgia	Jul. 08	AQ
Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya? for the Management of Fibromyalgia	Jul. 08	CI
Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program	Jul. 01	AQ
Tonix Pharmaceuticals Receives Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program	Jul. 01	CI
Tonix Pharmaceuticals Closes $4 Million Offering	Jun. 28	MT
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering	Jun. 28	AQ
Top Midday Decliners	Jun. 27	MT
Wall Street Set to Open Marginally Lower Thursday as Investors Parse Bullish Economic Data	Jun. 27	MT
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering	Jun. 27	AQ
US Futures Trend Lower Pre-Bell as Investors Await Slew of Economic Data	Jun. 27	MT
Top Premarket Decliners	Jun. 27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Tonix Pharmaceuticals Holding Corp Nasdaq

Equities

US8902602015

Summary

Filters